Phase III study to evaluate the use of high-dose chemotherapy as consolidation of treatment for high-risk postoperative breast cancer: Japan Clinical Oncology Group study, JCOG 9208.

Source:http://linkedlifedata.com/resource/pubmed/id/17970786

Download in:

View as

General Info

PMID
17970786